InvestorsHub Logo
Followers 26
Posts 600
Boards Moderated 0
Alias Born 12/05/2013

Re: None

Friday, 04/25/2014 3:32:36 PM

Friday, April 25, 2014 3:32:36 PM

Post# of 9944
Respect

Something that is hard to gain for this drug.

"It cures many types of cancer with no side effects?...bullshit!"

I have heard that a lot from people I talk to....actually most...and when I see them dismiss my conversation 30 seconds in, I want to punch them in the mouth....after all, they got their broker to do that research and everybody knows that they have the background to understand the science.....

Does it have respect from the decision makers of big pharmas who went another path and spent billions at a failing drug? They dare not say they missed this one.....they already look dumb enough. What about all those researchers who are tied up with other oncology drugs? They know which side their bread is buttered on. Peer reviewed journals.....ever hear their disdain for commercial scientists? The press? Those that spend millions and millions in advertising get the golden treatment.

So who does respect this drug? Moffit..yes...MD Anderson...the ones here who were not lazy and did their homework...the list is growing. When we get an uplisting and BTD then we will start getting the respect this drug deserves.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PVCT News